155 BOVET RD., SUITE 303, SAN MATEO, CA
Market cap: $194.7M (12/18/2025)
Price: $6.28
Investor Presentation
Announce Global License Agreement for Innovative Forms of Resmetirom API for Fixed Dose Combination Program
Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
News, Letter Re Change in Certifying Accountant
News, Legal Opinion, Material Contracts
Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
Material disclosure
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(4)
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence